# Treatment Protocol for Clofazamine in the Long Term Treatment of Leprosy

> **NCT00852345** · — · NO_LONGER_AVAILABLE · sponsor: **Kaiser Permanente**

## Conditions studied

- Leprosy

## Interventions

- **DRUG:** clofazamine

## Key facts

- **NCT ID:** NCT00852345
- **Lead sponsor:** Kaiser Permanente
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2015-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00852345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00852345, "Treatment Protocol for Clofazamine in the Long Term Treatment of Leprosy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00852345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*